Cargando…
Emerging Nondopaminergic Medications for Parkinson’s Disease: Focusing on A(2A) Receptor Antagonists and GLP1 Receptor Agonists
Parkinson’s disease (PD) is a severe neurodegenerative disease characterized by classic motor features associated with the loss of dopaminergic neurons and appearance of Lewy bodies in the substantia nigra. Due to the complexity of PD, a definitive diagnosis in the early stages and effective managem...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Movement Disorder Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490190/ https://www.ncbi.nlm.nih.gov/pubmed/34399565 http://dx.doi.org/10.14802/jmd.21035 |